PMC:7441788 / 3292-3450 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T37","span":{"begin":3,"end":17},"obj":"Disease"},{"id":"T38","span":{"begin":87,"end":95},"obj":"Disease"},{"id":"T39","span":{"begin":132,"end":140},"obj":"Disease"}],"attributes":[{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0004609"},{"id":"A38","pred":"mondo_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"nd herpes simplex virus [9]. This article reviews the current status of CQ/HCQ against SARS-CoV-2 and their use in the treatment of COVID-19.\n\n2. Antiviral a"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T22","span":{"begin":18,"end":23},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"nd herpes simplex virus [9]. This article reviews the current status of CQ/HCQ against SARS-CoV-2 and their use in the treatment of COVID-19.\n\n2. Antiviral a"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T40","span":{"begin":72,"end":74},"obj":"Chemical"}],"attributes":[{"id":"A40","pred":"chebi_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"nd herpes simplex virus [9]. This article reviews the current status of CQ/HCQ against SARS-CoV-2 and their use in the treatment of COVID-19.\n\n2. Antiviral a"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T25","span":{"begin":72,"end":74},"obj":"Chemical"}],"attributes":[{"id":"A25","pred":"chebi_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"nd herpes simplex virus [9]. This article reviews the current status of CQ/HCQ against SARS-CoV-2 and their use in the treatment of COVID-19.\n\n2. Antiviral a"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T33","span":{"begin":10,"end":23},"obj":"Species"},{"id":"T34","span":{"begin":87,"end":97},"obj":"Species"},{"id":"T35","span":{"begin":132,"end":140},"obj":"Species"}],"attributes":[{"id":"A33","pred":"ncbi_taxonomy_id","subj":"T33","obj":"NCBItxid:10294"},{"id":"A34","pred":"ncbi_taxonomy_id","subj":"T34","obj":"NCBItxid:2697049"},{"id":"A35","pred":"ncbi_taxonomy_id","subj":"T35","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"nd herpes simplex virus [9]. This article reviews the current status of CQ/HCQ against SARS-CoV-2 and their use in the treatment of COVID-19.\n\n2. Antiviral a"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T29","span":{"begin":29,"end":141},"obj":"Sentence"},{"id":"T30","span":{"begin":143,"end":145},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"nd herpes simplex virus [9]. This article reviews the current status of CQ/HCQ against SARS-CoV-2 and their use in the treatment of COVID-19.\n\n2. Antiviral a"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"103","span":{"begin":72,"end":78},"obj":"Gene"},{"id":"110","span":{"begin":87,"end":97},"obj":"Species"},{"id":"131","span":{"begin":132,"end":140},"obj":"Disease"}],"attributes":[{"id":"A110","pred":"pubann:denotes","subj":"110","obj":"Tax:2697049"},{"id":"A131","pred":"pubann:denotes","subj":"131","obj":"MESH:C000657245"}],"text":"nd herpes simplex virus [9]. This article reviews the current status of CQ/HCQ against SARS-CoV-2 and their use in the treatment of COVID-19.\n\n2. Antiviral a"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T18","span":{"begin":18,"end":23},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T19","span":{"begin":147,"end":156},"obj":"http://purl.obolibrary.org/obo/IDO_0000559"}],"text":"nd herpes simplex virus [9]. This article reviews the current status of CQ/HCQ against SARS-CoV-2 and their use in the treatment of COVID-19.\n\n2. Antiviral a"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T31","span":{"begin":3,"end":17},"obj":"Disease"},{"id":"T32","span":{"begin":87,"end":97},"obj":"Disease"},{"id":"T33","span":{"begin":132,"end":140},"obj":"Disease"}],"attributes":[{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0004609"},{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A33","pred":"mondo_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"nd herpes simplex virus [9]. This article reviews the current status of CQ/HCQ against SARS-CoV-2 and their use in the treatment of COVID-19.\n\n2. Antiviral a"}

{"project":"LitCovid-PubTator","denotations":[{"id":"103","span":{"begin":72,"end":78},"obj":"Gene"},{"id":"110","span":{"begin":87,"end":97},"obj":"Species"},{"id":"131","span":{"begin":132,"end":140},"obj":"Disease"}],"attributes":[{"id":"A110","pred":"tao:has_database_id","subj":"110","obj":"Tax:2697049"},{"id":"A131","pred":"tao:has_database_id","subj":"131","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"nd herpes simplex virus [9]. This article reviews the current status of CQ/HCQ against SARS-CoV-2 and their use in the treatment of COVID-19.\n\n2. Antiviral a"}

{"project":"LitCovid-sentences","denotations":[{"id":"T29","span":{"begin":29,"end":141},"obj":"Sentence"},{"id":"T30","span":{"begin":143,"end":145},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"nd herpes simplex virus [9]. This article reviews the current status of CQ/HCQ against SARS-CoV-2 and their use in the treatment of COVID-19.\n\n2. Antiviral a"}

{"project":"2_test","denotations":[{"id":"32496926-20466822-132195654","span":{"begin":25,"end":26},"obj":"20466822"}],"text":"nd herpes simplex virus [9]. This article reviews the current status of CQ/HCQ against SARS-CoV-2 and their use in the treatment of COVID-19.\n\n2. Antiviral a"}